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ABSTRACT
As a results of the case report “Post-rotavirus vaccine intussusception in identical twins: a case report”
recently published on Human Vaccines & Immunotherapy by La Rosa et al., the principal Sicilian Public
Health Authorities decided to specify several points and underline some important details omitted by the
authors. In particular, aims to underline the remarkable beneﬁt for Sicilian Regional Health service after the
introduction of the rotavirus vaccination.
Universal mass vaccination against rotavirus is properly managed by the Regional Health Authorities and is
contributing to a consistent increase of public health in the Sicilian pediatric population; any modiﬁcation
of such a program should be based on robust scientiﬁc evidences. Finally, a single case report should not
be considered as a basis to recommend a change in the clinical practice but instead a possible point of
start for discussion and research.
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Dear Sirs,
We read with interest the paper by La Rosa et al “Post-rota-
virus vaccine intussusception in identical twins: a case report”
recently published on Human Vaccines & Immunotherapy.1
In our opinion, some points need to be speciﬁed, in particu-
lar to underline the remarkable beneﬁt for Sicilian Regional
Health service after the introduction of the universal mass vac-
cination against rotavirus (UMRV), that was omitted by the
authors.1
G.G. and Y are two identical twins, born in Province of
Catania, the 16th of June 2013. The twins were born at a
gestational age of 36 C 0 weeks, that was internationally
recognized as a preterm birth, and not an "at term" birth
how reported.1,2
Weight (in grams), length and cranial circumference (in
centimeters) at birth were 2,150 - 31 - 46 (for X), and 2,050 -
31.5 - 46 (for Y) respectively. The 3rd of September 2013 the
pediatrician correctly recommended, according to the Regional
Immunization Schedule approved in 2012 and become law the
1st of January 2013, the oral administration of monovalent
rotavirus vaccine (RV1) for both twins.3
We agree with the Authors that universal mass vaccination
against rotavirus (UMVR) exerts a large public health impact
on rotavirus burden of disease. Sicily was the ﬁrst region in
Italy to introduce UMVR in 2012. After the ﬁrst year, a 40%
reduction of rotavirus gastroenteritis hospitalization among
children aged 0-59 months was recorded, in spite of suboptimal
vaccination coverage, consistently with ﬁgures observed in
other European Countries.4-9
Nevertheless, in the paper by La Rosa et al there are some
statements that, in our opinion, deserve further discussion as
summarized below:
1) The use of monovalent rotavirus vaccine (RV1) is
approved for preterm babies and such a vaccination is
internationally recommended.10,11 Intussusception insur-
gence was probably related with several factors (viral or
bacterial infections, feeding, familiar predisposition, use
of drugs, …) and was reported only a marginal role of
the new generation of rotavirus vaccine.12-15 However,
the preterm condition might act as a confounding factor
to the occurrence of intussusception in the twins.
2) Being the twins been born in June 2013, the vaccine was
administered in September 2013 and not in 2014 as
reported.1 RV1 vaccination after 24 weeks of age would
have constitute an off label administration, as speciﬁed in
the Summary of the Product Characteristics (SmPC).10
3) In Sicily, all the public health providers, including pedia-
tricians, are trained and requested to follow the Regional
Immunization Schedule, verifying the absence of vaccine
contraindication in babies and children and counseling
the families for a consciousness adherence to vaccination
programs.4,7 Thus, the sentence reported in the paper by
La Rosa et al. (“ …on the advice of the pediatrician..”)
should be interpreted in this light.
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4) Health care providers and pediatricians in Sicily properly
report any intussusception case. Such an attitude
reﬂected in an increasing trend of intussusception hospi-
talizations among children aged 0-59 months in the pre-
rotavirus vaccination period, due to contributing factors
different from RV vaccination (2003-2012).14,16 Twins
were hospitalized for intussusception 7 and 8 d after vac-
cine ﬁrst dose administration, respectively. Such a time
frame is in line with the ﬁndings of different post mar-
keting surveillance studies and the monovalent vaccine
SmPC.10,15, 17 In fact, an increase of 1.6 intussusception
cases out of 100.000 vaccinations was recently postulated
on the basis of the VAERS monitoring in the USA after
nearly 11 million of doses of RV1 distributed.18 For the
time being, the rate of RV1 temporarily associated intus-
susceptions in Sicily is in line with such an estimate.
5) In January 2016, started a case control study that will
investigate all invagination cases hospitalized in Sicily
from 2009 to 2014, comparing socio-demographics,
neonatal, feeding, familiar, pharmacological and
genetic factors (through an oral swab), with control
children comparable for gender, gestational age and
environmental characteristics. Familiarity of intussus-
ceptions hypothesized by authors, is an intriguing
theory. However the interview of the twins’ mother
and family pediatrician, recently carried out during
the study, reduced the link with an intussusception
familiarity. As a matter of fact, any twins relative,
including parents and the 2 older brothers had never
experienced any episode of intussusceptions. The
statements made by La Rosa et al in the paper on
this potential association lack of scientiﬁc evidence
(and references) and thus should be framed as an
authors personal opinions.
6) Finally, during the interview, emerged the use of drugs
for both twins in the 2 d preceding the hospitalization
for intussusception. In particular, from the 9th of
September 2013, due to an urinary tract infection, was
administered to X an antibiotic (Cefpodoxime) and,
from the same day, due to a bronchospasm with associ-
ated cough, were administered to Y a nebulized solution
of salbutamol and ipratropium bromide. This possible
confounding factor was supported by several studies that
analyzed the possible role in particular of antibiotics in
intussusception insurgence.19-21
In conclusion, in agreement with the Evidence Based
Medicine concept, we believe that a single case report
should not be considered as a basis to recommend a modi-
ﬁcation in the clinical practice but instead a possible point
of start for scientiﬁcally sound discussion and research, if
needed. UMVR is properly managed by the Regional Health
Authorities and is contributing to a consistent increase of
public health in the Sicilian population; any modiﬁcation of
such a program should be based on robust scientiﬁc
evidences.
Disclosure of potential conﬂicts of interest
No potential conﬂicts of interest were disclosed.
References
[1] La Rosa F, Scuderi MG, Taranto V, La Rosa V, Spinello CM, La
Camera G, Astuto M. Post-rotavirus vaccine intussusception in iden-
tical twins: a case report. Hum Vaccin Immunother 2016; Apr 12:1-3.
[2] World Health Organization. Preterm birth - Fact sheet N 363
(Updated November 2015). Available online at: http://www.who.int/
mediacentre/factsheets/fs363/en/ (cited 2016 May 27)
[3] Health Department Decree n 0820/2012. “Calendario Vaccinale per
la Vita:” modiﬁcation and integration of the Sicilian Regional immu-
nization schedule. Available online at: http://www.epicentro.iss.it/
temi/vaccinazioni/pdf/Normative/Sicilia%20_%20Maggio%202012/
CALENDARIO%202012/Delibera%20D.A.%20n%C2%B0%200820-
12%20del%207.5.12.pdf (cited 2016 May 27)
[4] Costantino C, Amodio E, Vitale F. Impact on rotavirus gastro-
enteritis hospitalisation during the ﬁrst year of universal vaccination
in Sicily. Paediatr Int Child Health 2015; 35(4):342-3;
PMID:26744161; http://dx.doi.org/10.1080/20469047.2015.1109240
[5] Rationale for Italian Lifetime Immunization Schedule (2nd edition).
Available online at: http://www.vaccinarsi.org/assets/uploads/ﬁles/359/
Calendario_per_la_vita_2014_FINALE.pdf (cited-2016-May-27)
[6] Signorelli C, Odone A, Bonanni P, Russo F. New Italian immunisa-
tion plan is built on scientiﬁc evidence: Carlo Signorelli and col-
leagues reply to news article by Michael Day. BMJ 2015; Dec 14; 351:
h6775; PMID:26667823; http://dx.doi.org/10.1136/bmj.h6775
[7] Ofﬁcial Gazzette of Sicilia Region. Health Department Decree
12/01/2015. Modiﬁcation and Integration of the “Calendario
Vaccinale per la Vita.” Available from: http://pti.regione.sicilia.
it/portal/page/portal/PIR_PORTALE/PIR_LaStrutturaRegionale/
PIR_AssessoratoSalute/PIR_Decreti/PIR_Decreti2015/PIR_Decre
tiassessorialianno2015/12%2001%202015%20SERV%201%20(38).
pdf (cited 2016 May 27)
[8] Paulke-Korinek M, Kundi M, Rendi-Wagner P, de Martin A, Eder G,
Schmidle-Loss B. Herd immunity after two years of the universal
mass vaccination program against rotavirus gastroenteritis in
Austria. Vaccine 2011; 29:2791-6; PMID:21320539; http://dx.doi.
org/10.1016/j.vaccine.2011.01.104
[9] Raes M, Strens D, Vergison A, Verghote M, Standaert B. Reduction
in pediatric rotavirus-related hospitalizations after universal rotavi-
rus vaccination in Belgium. Pediatr Infect Dis J 2011; 30:e120-5;
PMID:21436757; http://dx.doi.org/10.1097/INF.0b013e318214b811
[10] Monovalent human rotavirus vaccination technical sheet. Available
from: ec.europa.eu/health/documents/community-register/2006/200
6022110930/anx_10930_it.pdf (cited 2016 May 27)
[11] Vesikari T, Van Damme P, Giaquinto C, Dagan R, Guarino A,
Szajewska H, Usonis V. European Society for Paediatric Infectious
Diseases consensus recommendations for rotavirus vaccination in
Europe: update 2014. Pediatr Infect Dis J 2015; Jun; 34(6):635-43;
PMID:25860532; http://dx.doi.org/10.1097/INF.0000000000000683
[12] Fischer TK, Bihrmann K, Perch M, Koch A, Wohlfahrt J, Ka

re M,
Melbye M. Intussusception in early childhood: a cohort study of 1.7 mil-
lion children. Pediatrics 2004; Sep; 114(3):782-5; PMID:15342854;
http://dx.doi.org/10.1542/peds.2004-0390
[13] Samad L, Cortina-Borja M, Bashir HE, Sutcliffe AG, Marven S, Cameron
JC, Lynn R, Taylor B. Intussusception incidence among infants in the UK
and Republic of Ireland: a pre-rotavirus vaccine prospective surveillance
study. Vaccine 2013; Aug 28; 31(38):4098-102; PMID:23871447; http://
dx.doi.org/10.1016/j.vaccine.2013.06.084
[14] Nylund CM, Denson LA, Noel JM. Bacterial enteritis as a risk factor
for childhood intussusception: A retrospective cohort study. J Pediatr
2010; 156(5):761-5; PMID:20138300; http://dx.doi.org/10.1016/j.
jpeds.2009.11.026
[15] Patel MM, Lopez-Collada VR, Bulh~oes MM, De Oliveira LH,
Bautista Marquez A, Flannery B, Esparza-Aguilar M, Montenegro
Renoiner EI, Luna-Cruz ME, Sato HK, et al. Intussusception risk and
health beneﬁts of rotavirus vaccination in Mexico and Brazil. N Engl
J Med 2011; 364(24):2283-92; PMID:21675888; http://dx.doi.org/
10.1056/NEJMoa1012952
[16] Costantino C, Restivo V, Cuccia M, Furnari R, Amodio E, Vitale
F. Analysis of hospitalizations due to intussusception in Sicily in
2970 F. VITALE ET AL.
the pre-rotavirus vaccination era (2003-2012). Ital J Pediatr 2015;
Aug 1; 41:52; PMID:26232152; http://dx.doi.org/10.1186/s13052-
015-0160-4
[17] Palupi-Baroto R, Lee KJ, Carlin JB, Bines JE. Intussusception in
Australia: epidemiology prior to the introduction of rotavirus vac-
cine. Aust N Z J Public Health 2015; Feb; 39(1):11-4;
PMID:25558780; http://dx.doi.org/10.1111/1753-6405.12297
[18] Haber P, Parashar UD, Haber M, DeStefano F. Intussusception
after monovalent rotavirus vaccine-United States, Vaccine
Adverse Event Reporting System (VAERS), 2008-2014. Vaccine
2015; Sep 11; 33(38):4873-7; PMID:26276687; http://dx.doi.org/
10.1016/j.vaccine.2015.07.054
[19] Hviid A, Svanstrom H. Antibiotic use and intussusception in
early childhood. J Antimicrob Chemother 2009; 64:642-8;
PMID:19549670; http://dx.doi.org/10.1093/jac/dkp217
[20] Spiro DM, Arnold DH, Barbone F. Association between antibiotic
use and primary idiopathic intussusception. Arch Pediatr Adolesc
Med 2003; 157:54-9; PMID:12517195; http://dx.doi.org/10.1001/
archpedi.157.1.54
[21] Jenke AC, Klaassen-Mielke R, Zilbauer M, Heininger U, Trampisch
H, Wirth S. Intussusception: incidence and treatment-insights from
the nationwide German surveillance. J Pediatr Gastroenterol Nutr
2011; Apr; 52(4):446-51; PMID:21415671; http://dx.doi.org/10.1097/
MPG.0b013e31820e1bec
HUMAN VACCINES IMMUNOTHERAPEUTICS 2971
